Benzinga | Feb 4, 2021 04:27PM EST

Neurocrine Biosciences Q4 EPS $0.91 Beats $0.54 Estimate, Sales $247.90M Miss $262.40M Estimate

Neurocrine Biosciences (NASDAQ:NBIX) reported quarterly earnings of $0.91 per share which beat the analyst consensus estimate of $0.54 by 68.52 percent. This is a 13.33 percent decrease over earnings of $1.05 per share from the same period last year. The company reported quarterly sales of $247.90 million which missed the analyst consensus estimate of $262.40 million by 5.53 percent. This is a 1.56 percent increase over sales of $244.10 million the same period last year.